MSB 1.74% $1.42 mesoblast limited

Cell Therapy News/Articles, page-17627

  1. 1,311 Posts.
    lightbulb Created with Sketch. 369
    So this is for approval for use in South Korea (LTH's please ignore what must be irritating questions to you) - am I right in thinking Remestemcel-L has approval already in Japan and Canada?

    Is that correct - and are there other countries this newbie is unaware of (I'm trying really hard to catch up but 20 yrs is a LOT of reading!)

    Cheers
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.